Cambridge Nutritional Sciences (LSE:CNSL) Other Current Receivables: £0.37 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Cambridge Nutritional Sciences Other Current Receivables?

Cambridge Nutritional Sciences LSE:CNSL Other Current Receivables is £0.37 Mil as of Mar. 2026. The stock has 4 warning signs investors should review.

Cambridge Nutritional Sciences's Other Current Receivables for the quarter that ended in Mar. 2026 was £0.37 Mil.

Cambridge Nutritional Sciences's quarterly Other Current Receivables declined from Mar. 2025 (£0.31 Mil) to Sep. 2025 (£0.00 Mil) but then increased from Sep. 2025 (£0.00 Mil) to Mar. 2026 (£0.37 Mil).

Cambridge Nutritional Sciences's annual Other Current Receivables increased from Mar. 2024 (£0.24 Mil) to Mar. 2025 (£0.31 Mil) and increased from Mar. 2025 (£0.31 Mil) to Mar. 2026 (£0.37 Mil).

Cambridge Nutritional Sciences Other Current Receivables Related Terms

Cambridge Nutritional Sciences Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Cambridge Nutritional Sciences's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cambridge Nutritional Sciences Other Current Receivables Chart

Cambridge Nutritional Sciences Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.43 0.42 0.24 0.31 0.37

Cambridge Nutritional Sciences Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.24 0.00 0.31 0.00 0.37

Cambridge Nutritional Sciences Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of £0.37 Mil mean?
Cambridge Nutritional Sciences (LSE:CNSL) has a Other Current Receivables of £0.37 Mil as of Mar. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Cambridge Nutritional Sciences and its competitors.
Is Cambridge Nutritional Sciences' Other Current Receivables too high?
Cambridge Nutritional Sciences' current Other Current Receivables is £0.37 Mil.
How does Cambridge Nutritional Sciences' Other Current Receivables compare to ISRG and BDX?
Cambridge Nutritional Sciences' Other Current Receivables of £0.37 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Medical Devices & Instruments company?
A good Other Current Receivables depends on the Medical Devices & Instruments industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Cambridge Nutritional Sciences and its competitors. Cambridge Nutritional Sciences's current Other Current Receivables is £0.37 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cambridge Nutritional Sciences stock overvalued right now?
Based on GuruFocus' analysis, Cambridge Nutritional Sciences (LSE:CNSL) is currently considered Modestly Undervalued. The stock's GF Value™ is £0.02, compared to a current price of £0.01 — trading 27.5% below its estimated fair value. The current Other Current Receivables is £0.37 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Cambridge Nutritional Sciences (LSE:CNSL), the current Other Current Receivables is £0.37 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cambridge Nutritional Sciences Business Description

Other Exchanges RVKA:Germany
Address One Fleet Place, London, GBR, EC4M 7WS
Omega Diagnostics Group PLC is a UK-based medical diagnostics company. It develops, manufactures, and distributes in vitro diagnostic tests, historically organized around food sensitivity testing, allergy and autoimmune testing, and infectious disease diagnostics. Its food sensitivity products, marketed under brands such as Food Detective and FoodPrint, are used by healthcare professionals and laboratories to identify immune reactions to foods. The company also supplies allergy testing kits and, during the COVID-19 pandemic, produced lateral flow antigen tests. Omega serves customers including clinical laboratories, hospitals, research institutions, and healthcare providers, selling primarily in the United Kingdom, Europe, and through distributors in other international markets. Revenue is generated through the sale of diagnostic test kits and related consumables, with additional income from contract manufacturing and licensing arrangements. The company has undergone significant restructuring, including the sale of its infectious disease business and a rebranding of its food sensitivity operations.